New insights into the possible role of bacteriophages in host defense and disease

Medical Immunology

Volumn 2, Issue , 2003, Pages

  Gorski, Andrzej ^a,b   Dabrowska, Krystyna ^a   Switala Jele, Kinga ^a   Nowaczyk, Maria ^a   Weber Dabrowska, Beata ^a   Boratynski, Janusz ^a   Wietrzyk, Joanna ^a   Opolski, Adam ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD40 LIGAND;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BACTERIOLYSIS; BACTERIOPHAGE; BINDING AFFINITY; CELL INTERACTION; CELL MIGRATION; DOWN REGULATION; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; HOST RESISTANCE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PROTEIN BINDING; T LYMPHOCYTE; THROMBOCYTE;

EID: 0842269921     PISSN: 14769433     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-9433-2-2     Document Type: Article

References (51)

1. Stone R Stalin's forgotten cure. Science 2002, 298:728-731
2. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM and Baird A Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 2002, 3:45-57
3. Weber-Dabrowska B, Mulczyk M and Górski A Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp 2000, 48:547-551
4. Sulakvelidze A, Alavidze Z and Morris JG Bacteriophage therapy. Antimicrob Agents Chemother 2001, 45:649-659
5. Merril CR, Friedman TB, Attallah AFM, Geier MR, Krell K and Yarkin R Isolation of bacteriophages from commercial sera. In Vitro 1972, 8:91-93
6. Gantzer C, Henny J and Schwartzbrod L Bacterioides fragilis and Escherichia coli bacteriophages in human faeces. Int J Hyg Environ Health 2002, 205:324-328
7. Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R and Steiberg D Bacteriophage isolation from human saliva. Lett Appl Microbiol 2003, 36:50-53
8. Kamme C Antibodies against staphylococcal bacteriophages in human sera. I. Assay of antibodies in healthy individuals and in patients with staphylococcal infections. Acta Pathol Microbiol Scand (B) Microbiol Immunol 1973, 81:741-748
9. Hedstrom SA and Kamme C Antibodies against staphylococcal bacteriophages in human sera. II. Assay of antibodies in exacerbation and regression of chronic staphylococcal osteomyelitis. Acta Path Microbiol Scand (B) 1973, 81:749-752
10. Kucharzewicz-Krukowska A and Slopek S Immunogenic effects of bacteriophage in patients subjected to phage therapy. Arch Immun Ther Exp 1987, 35:553-561
11. Ochs HD, Davis SD and Wedgwood RJ Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest 1971, 50:2559-1568
12. Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vicinsky E and Wedgwood RJ Immune response after splenectomy Lancet 1978, 18:178-181
13. Fogelman I, Davey V, Ochs HD, Elashoff M, Feinberg MB, Mican J, Siegel JP, Sneller M and Lane HC Evaluation of CD4+ T cell function in vivo in HIV-infected patients as measured by bacteriophage phi 174 immunization. J Infect Dis 2000, 182:435-441
14. Shearer WT, Lugg DJ, Rosenblatt HM, Nickoll PM, Sharp RM, Reuben JM and Ochs HD Antibody responses to bacteriophage phi X-174 in human subjects exposed to the antarctic wind - over model of spaceflight J Allergy Clin Immunol 2001, 107:19-20
15. Rubinstein A, Mizrachi Y, Bernstein L, Shliozberg J, Goldener M, Liu GQ and Ochs DH Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X 174 in asymptomatic HIV-1 infected patients. AIDS 2000, 14:F55-62
16. Bohnsack J, Ochs HD, Wedgewood RJ and Heller SR Antibody to bacteriophage phi X 174 synthesized by cultured human peripheral blood lymphocytes. Clin Exp Immunol 1985, 59:673-678
17. Wenger SL, Turner JH and Petricciani JC The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytes. In Vitro 1978, 14:543-549
18. Merril CR, Geier MR and Petricciani JC Bacterial virus gene expression in human cells. Nature 1971, 233:398-400
19. Di Giovine M, Salone B, Martina Y, Amati V, Zambruno G, Cundari E and Failla CM Saggio Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology 2001, 282:102-112
20. Lederberg J Smaller fleas... ad infinitum: therapeutic bacteriophage redux. Proc Nat Acad Sci USA 1996, 93:3167-3168
21. Bloch H Experimental investigation on the relationships between bacteriophages and malignant tumors. Arch Virol 1940, 1:481-496(in German)
22. Kañtoch M and Mordarski M Binding of bacterial viruses by cancer cells in vitro. Post Hig Med Dosw 1958, 12:191-192(in Polish)
23. Kañtoch M Studies on phagocytosis of bacterial viruses. Arch Immun Ther Exp 1958, 6:63-84(in Polish)
24. Lafrenie RM, Lee SF, Hewlett IK, Yamada KM and Dhawan S Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes. Virology 2002, 297:31-38
25. Triantafilou K, Takada Y and Triantafilou M Mechanism of integrin - mediated virus attachment and internalization process. Crit Rev Immunol 2001, 21:311-322
26. Gavrilovskaya IN, Brown EJ, Ginsberg MH and Mackow ER Cellular entry of hantavirus which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 1999, 73:3951-3959
27. Ling WL, Longley RL, Brassard DL, Armstrong L and Schaefer EJ Role of integrin alphavbeta3 in the production of recombinant adenovirus in HEK - 293 cells. Gene Ther 2002, 9:907-914
28. De Meester I, Korom S, Van Damme J and Scharpe S CD26, let it cut or cut it down. Immunol Today 1999, 20:367-375
29. Ohtsuki T, Tsuda H and Morimoto C Good or evil: CD26 and HIV infection. J Dermatol Sci 2000, 22:152-160
30. Pohlmann S, Baribaud F and Doms RW DC-SING and DC-SIGNR: helping hands for HIV. Trends Immunol 2001, 22:643-646
31. Halary F, Amara A, Lortat-Jacob H, Messerle M and Delauncy T Human Cytomegalovus binding DC- SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17:653-664
32. Simmons G, Reeves JD and Grogan GC DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123
33. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R and Ross SR Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Nat Acad Sci USA 2002, 99:2281-2286
34. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalia Z and Garofalo RP Respiratory syncytial virus - induced activation of NF-kappaB in the lung involves alveolar macrophages and toll-like receptor 4 - dependent pathways. J Infect Dis 2002, 186:1199-1206
35. Philips DR, Charo IF and Scarborough RM GPIIb - IIIa: the responsive integrin. Cell 1991, 65:359-362
36. Weerasinghe D, McHugh KP, Ross FP, Brown EJ and Gisler RH A role of the αvβ3 integrin in the transmigration of monocytes. J Cell Biol 1998, 142:595-607
37. Trikha M, Zhou T, Timar J, Raso E, Kennel M, Emmel E and Nakada MT Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 2002, 62:2824-2833
38. Trikha M, Raso E and Cai Y Role of alphaIIbbeta3 integrin in prostate cancer metastasis. Prostate 1998, 15:185-192
39. Andre P, Prasad KSS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR and Wagner DD CD40L stabilizes arterial thrombi by a β3 integrin - dependent mechanism. Nature Med 2002, 8:247-252
40. Biancone L, Cantaluppi V and Camussi G CD40-CD40L interactions in experimental and human disease (review). Int J Mol Med 1999, 3:343-353
41. Andre P, Nannizzi-Alaimo L, Prasad SK and Phillips DR Platetet - derived CD40L. The switch-hitting player in cardiovascular disease. Circulation 2002, 106:896-899
42. Gitis V, Adin A, Nasser A, Gun J and Lev O Fluorescent dye labeled bacteriophages - a new tracer for the investigation of viral transport in porous media. Water Res 2002, 36:4227-4234
43. Lefkovits J, Plow EF and Topol EJ Mechanisms of disease: platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995, 332:1553-1559
44. Nair S, Ghosh K, Kulkarni B, Shetty S and Mohanty D Glanzmann's thrombastenia: updated. Platelets 2002, 13:387-393
45. Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC and Armstrong L Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp Cell Res 1999, 251:33-45
46. Massberg S, Brand K and Gruner S A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887-896
47. Elson CO and Cong Y Understanding immune-microbial homeostasis in intestine. Immunol Res 2002, 26:87-94
48. Dom RW and Trono D The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 2000, 14:2677-2688
49. Levy JA Is HIV superinfection worrisome? Lancet 2003, 361:98-99
50. Marteau P, Seksik P and Jian R Probiotics and health: new facts and ideas. Curr Opin Biotechnol 2002, 13:486-489
51. Cross MC Microbes versus microbes: immune signals generated by probiotic lactobaccilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 2002, 34:245-253